Have you got room for a blue chip or two in your portfolio? If you are, then take a look at the blockbuster blue chip shares listed below.
Here’s why they are highly rated:
CSL Limited (ASX: CSL)
The first blue chip for investors to look at is one that many investors regard as the highest quality company on the Australian share market – CSL.
It is one of the world’s leading biotechnology companies, comprising the CSL Behring and Seqirus businesses. Both are leaders in their respective fields – plasma therapies and vaccines.
And while plasma collection headwinds have been weighing on collections and investor sentiment again this year, CSL appears well-placed for growth once conditions ease. Particularly given strong demand for its immunoglobulins and vaccines, and its lucrative R&D pipeline. The latter is full of potential therapies that could boost sales materially in the future.
Macquarie is a fan of CSL. Last week it upgraded the company’s shares to an outperform rating with a $338.00 price target. This compares to the most recent CSL share price of $309.00.
REA Group Limited (ASX: REA)
Another blue chip share for investors to look at is REA Group. It is the dominant player in real estate listings in the Australian market.
REA Group looks well-placed for growth in the coming years for a number of reasons. These include the booming housing market, new revenue streams, cost cutting, price increases, its international operations, and acquisitions. The latter has seen the company grow its presence in mortgage broking through the acquisition of Mortgage Choice.
Macquarie is also very positive on REA Group and has an outperform rating and $192.00 price target on its shares. This compares to the latest REA Group share price of $171.79.